Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Medicine (Baltimore) ; 102(15): e33488, 2023 Apr 14.
Article in English | MEDLINE | ID: covidwho-2301106

ABSTRACT

Coronavirus disease-19 (COVID-19) is a global pandemic, with a high capability of contagious distribution, where national secondary and co-infections characterization are lacking. The objective of this study was to assess the impact of the COVID-19 pandemic on infection rates among patients admitted to the intensive care units at King Abdullah University Hospital, profiling the drug resistance rates nationally. This is a cross-sectional study of COVID-19 associated infections that was conducted at a teaching hospital, in the north of Jordan. It included all COVID-19 patients who were admitted to intensive care units during the first and second pandemic waves. Data on age, gender, length of stay, co-morbidities, co-infections and sensitivity to antibiotics were retrospectively collected from the hospital information database. Statistical analyses were performed using SPSS software. A total of 589 COVID-19 patients were included, of whom 20% developed bacterial associated infections. The ratio of bacterial co-infection to secondary infections was 1:8. Gram-negative bacteria, Acinetobacter baumannii (40.1%), Eschericia coli (17.5%), Klebsiella pneumonia (6.8%), and Pseudomonas aeruginosa (5.1%) were the most abundant isolated species. The detection rates of E coli (ESBL), K pneumonia (ESBL), A baumannii (CRO), P aeruginosa (CRO), S aureus (MRSA) were 52%, 67%, 97%, 44%, and 67%, respectively.


Subject(s)
Bacterial Infections , COVID-19 , Coinfection , Cross Infection , Humans , Pandemics , Escherichia coli , Retrospective Studies , Cross-Sectional Studies , COVID-19/epidemiology , Cross Infection/epidemiology , Cross Infection/microbiology , Bacterial Infections/microbiology , Hospitals, Teaching , Anti-Bacterial Agents/therapeutic use , Microbial Sensitivity Tests , Pseudomonas aeruginosa , Intensive Care Units
SELECTION OF CITATIONS
SEARCH DETAIL